NRIX
Nurix TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NRIX vs peer average
18/100
NRIX vs. peer average (F vs. C)
Grade spread
A 2 · B 3 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CLDX is the first available peer comparator.
Celldex is the closest market-cap clinical-stage biotech comparator in the candidate set: valuation is also heavily event-driven by trial updates and regulatory path clarity rather than current product revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NRIX
Nurix Therapeutics
CLDX
Celldex Therapeutics
Grade
F
D
Momentum
78
65
Value
41
41
Sentiment
27
48
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs CLDX
NRIX / CLDX
Grade Position
Below peers
NRIX vs. peer average (F vs. C)
18/100
Momentum
78
NRIXValue
41
NRIXSentiment
27
CLDXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NRIX
CLDX is the first peer returned for this comparison set.